205 related articles for article (PubMed ID: 2258891)
1. Age, platelet serotonin kinetics and 5HT2-receptor blockade in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Hum Hypertens; 1990 Aug; 4(4):441-4. PubMed ID: 2258891
[TBL] [Abstract][Full Text] [Related]
2. Age and 5HT 2-receptor blockade with ketanserin in essential hypertension.
Bühler FR; Amstein R
Rev Port Cardiol; 1989 Sep; 8(9):621-4. PubMed ID: 2698721
[TBL] [Abstract][Full Text] [Related]
3. Platelet deactivation by 5HT2-receptor blockade parallels the antihypertensive response to ketanserin.
Amstein R; Fetkovska N; Pletscher A; Bühler FR
J Hypertens; 1989 Apr; 7(4):255-60. PubMed ID: 2723427
[TBL] [Abstract][Full Text] [Related]
4. Platelet serotonin-LDL interaction in essential hypertension.
Amstein R; Fetkovska N; Bühler FR
J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S35-40. PubMed ID: 1717771
[TBL] [Abstract][Full Text] [Related]
5. 5HT-kinetics and sensitivity of human blood platelets: variations with age, gender and platelet number.
Fetkovska N; Amstein R; Ferracin F; Regenass M; Bühler FR; Pletscher A
Thromb Haemost; 1988 Dec; 60(3):486-90. PubMed ID: 2467403
[TBL] [Abstract][Full Text] [Related]
6. Age and the platelet serotonin vasoconstrictor axis in essential hypertension.
Amstein R; Fetkovska N; Lüscher TF; Kiowski W; Bühler FR
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S35-40. PubMed ID: 2459512
[TBL] [Abstract][Full Text] [Related]
7. Impaired uptake of 5 hydroxytryptamine platelet in essential hypertension: clinical relevance.
Fetkovska N; Pletscher A; Ferracin F; Amstein R; Buhler FR
Cardiovasc Drugs Ther; 1990 Jan; 4 Suppl 1():105-9. PubMed ID: 1704794
[TBL] [Abstract][Full Text] [Related]
8. [In vivo platelet activation in mild arterial hypertension].
Guicheney P; Baudouin-Legros M; Meyer P
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):808-11. PubMed ID: 2959230
[TBL] [Abstract][Full Text] [Related]
9. Serotonin and preactivated platelets in essential hypertension.
Bühler FR; Amstein R; Fetkovska N
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S32-4. PubMed ID: 2446066
[TBL] [Abstract][Full Text] [Related]
10. Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets.
Bevan J; Heptinstall S
Thromb Res; 1983 Jun; 30(5):415-23. PubMed ID: 6612677
[TBL] [Abstract][Full Text] [Related]
11. Acute effect of urapidil on peripheral serotonin metabolism.
Sebeková K; Fedelesová V; Blazícek P; Dzúrik R
Cor Vasa; 1990; 32(4):274-81. PubMed ID: 2225876
[TBL] [Abstract][Full Text] [Related]
12. 5-Hydroxytryptamine kinetics and activation of blood platelets in patients with essential hypertension.
Fetkovska N; Amstein R; Ferracin F; Regenass M; Bühler FR; Pletscher A
Hypertension; 1990 Mar; 15(3):267-73. PubMed ID: 2137432
[TBL] [Abstract][Full Text] [Related]
13. Plasma serotonin levels and the platelet serotonin transporter.
Brenner B; Harney JT; Ahmed BA; Jeffus BC; Unal R; Mehta JL; Kilic F
J Neurochem; 2007 Jul; 102(1):206-15. PubMed ID: 17506858
[TBL] [Abstract][Full Text] [Related]
14. Serotonin and platelet activation during treatment with isradipine.
Fetkovska N; Sebekova K; Fedelesova V; Dzurik R
J Cardiovasc Pharmacol; 1991; 18 Suppl 3():S31-3. PubMed ID: 1720482
[TBL] [Abstract][Full Text] [Related]
15. Serotonin, hypertension and vascular disease.
Vanhoutte PM
Neth J Med; 1991 Feb; 38(1-2):35-42. PubMed ID: 2030808
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs.
van Zwieten PA; Blauw GJ; van Brummelen P
Clin Physiol Biochem; 1990; 8 Suppl 3():1-18. PubMed ID: 2132170
[TBL] [Abstract][Full Text] [Related]
17. Serotonin levels in hypertension.
Biondi ML; Agostoni A; Marasini B
J Hypertens Suppl; 1986 Apr; 4(1):S39-41. PubMed ID: 3457903
[TBL] [Abstract][Full Text] [Related]
18. Effects of urapidil on 5-hydroxytryptamine induced platelet aggregation and on 14C-5-hydroxytryptamine uptake in platelets.
Storck J; Ochs JG; Kirsten R
Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):303-8. PubMed ID: 2387654
[TBL] [Abstract][Full Text] [Related]
19. Serotonin and beta-thromboglobulin release reaction from platelet as triggered by interaction with polypeptide derivatives.
Kang IK; Ito Y; Sisido M; Imanishi Y
J Biomed Mater Res; 1988 Jul; 22(7):595-611. PubMed ID: 2969897
[TBL] [Abstract][Full Text] [Related]
20. Ketanserin (S2-receptor blocking agent), platelet activity and chronic alcoholism.
Santini P; Ceccanti M; De Lorenzo A; Pisculli M; Di Giovanni MG; Cavaleri G; Attilia ML; Berbellini A
Int J Clin Pharmacol Res; 1986; 6(1):73-6. PubMed ID: 2937746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
